Skip to content

Scailyte and CHU Rennes partnership for identifying Covid-19 patients

Scailyte and CHU Rennes have made an initial discovery of a single-cell biomarker for identification of covid19 patients at risk to become critically ill. We strive to deliver diagnostics that will allow pro-active clinical decisions and improve the outcome for Covid19 patients.

Recent News

Postdoc (Ph.D.) opportunity in Molecular Biology

This postdoctoral Research position in the laboratory of Endometriosis and Gynecological Oncology is

Read more

Recent News

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Read more

Recent News

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Read more

Recent News

Scailyte closes pre-series A financing round

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to furthe

Read more

Recent News

Scailyte and CHU Rennes partnership for identifying Covid-19 patients

Scailyte and CHU Rennes have made an initial discovery of a single-cell

Read more

Recent News

Scailyte announces its new advisory board

ScailyteTM is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to

Read more

Recent News

Scailyte ranked among the top100 Swiss startups in 2019

Scailyte ranked among the top100 Swiss startups in 2019. We are unlocking the full potential of Sing

Read more

Recent News

Using algorithms to track down cancer

Modern medicine is looking for markers that provide early warning of complex diseases. In its quest

Read more

Recent News

01 /04

Postdoc (Ph.D.) opportunity in Molecular Biology

This postdoctoral Research position in the laboratory of Endometriosis and Gynecological Oncology is

Read more

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Read more

Recent News

02 /04

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Read more

Scailyte closes pre-series A financing round

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to furthe

Read more

Recent News

03 /04

Scailyte and CHU Rennes partnership for identifying Covid-19 patients

Scailyte and CHU Rennes have made an initial discovery of a single-cell

Read more

Scailyte announces its new advisory board

ScailyteTM is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to

Read more

Recent News

04 /04

Scailyte ranked among the top100 Swiss startups in 2019

Scailyte ranked among the top100 Swiss startups in 2019. We are unlocking the full potential of Sing

Read more

Using algorithms to track down cancer

Modern medicine is looking for markers that provide early warning of complex diseases. In its quest

Read more

Recent News